| 发明名称 |
Mineralcorticoid receptor antagonist for producing drug for permanent treatment of endometriosis, comprises spironolactone, eplerenone and drospirenone |
| 摘要 |
<p>The mineralcorticoid receptor antagonist comprises spironolactone, eplerenone and drospirenone. Glucocorticoid, progesterone receptor antagonist and estrogen receptor antagonist are also included. The estrogen is ethinylestradiol. ACTIVITY : Gynecological. MECHANISM OF ACTION : Mineralcorticoid receptor antagonist; Gonadotropin-releasing hormone (GnRH) agonist.</p> |
| 申请公布号 |
DE102007011105(A1) |
申请公布日期 |
2008.09.04 |
| 申请号 |
DE20071011105 |
申请日期 |
2007.03.02 |
| 申请人 |
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT |
发明人 |
MOELLER, CARSTEN;KAUFMANN-REICHE, ULRIKE;SCHMIDT, ANJA;FUHRMANN, ULRIKE |
| 分类号 |
A61K45/00;A61P15/00 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
